Vashist Sandhu
About Vashist Sandhu
Data last updated:
Vashist Sandhu is a Director at Vaxova Drugs Private Limited (since 2021), Director at Alfavision Biotech Private Limited (since 2020) and Director at Deltis Pharma Private Limited (since 2021), and holds 1 more current directorship. The companies operate in Pharma. The 3 current companies with reported revenue have a combined latest revenue of ₹38.14 Cr; the largest is Vaxova Drugs Private Limited at ₹26.09 Cr (FY 2024). Earlier, Vashist Sandhu was a Director at Aconwell Pharma Private Limited (2020–2024) and Director at Anvicure Drugs Private Limited (2021–2024) and 1 more.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Vaxova Drugs Private Limited U74993HR2018PTC073704 | Director | 06 Mar 2021 | 2018 | ₹26.09 Cr (FY 2024) | Active |
 Alfavision Biotech Private Limited U24239HP2020PTC008176 | Director | 29 Oct 2020 | 2020 | ₹10.68 Cr (FY 2025) | Active |
 Deltis Pharma Private Limited U24304HR2020PTC087164 | Director | 05 Feb 2021 | 2020 | ₹1.37 Cr (FY 2023) | Active |
| Vaxova Life Sciences Private Limited U24299HP2021PTC008880 | Director | 08 Oct 2021 | 2021 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Aconwell Pharma Private Limited U24290HR2019PTC081592 | Director | 12 Nov 2020 | 2019 | ₹7.61 Cr (FY 2024) | Active |
 Anvicure Drugs Private Limited U74999HP2019PTC007326 | Director | 17 Apr 2021 | 2019 | ₹2.88 Cr (FY 2024) | Active |
| Indmark Biotech Private Limited U24290HR2021PTC097637 | Director | 13 Sep 2021 | 2021 | ₹1.03 Cr (FY 2025) | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Vashist Sandhu
| Name | DIN | Company | Designation |
|---|---|---|---|
| Ankush Kumar | 08115923 | Vaxova Drugs Private Limited , Vaxova Life Sciences Private Limited | Director |
| Narender | 08348728 | Vaxova Drugs Private Limited , Alfavision Biotech Private Limited and 1 more | Director |
| Rocky | 08516614 | Alfavision Biotech Private Limited | Director |
| Sachin Kumar | 10304242 | Alfavision Biotech Private Limited | Director |
| Sher Singh | 09569201 | Deltis Pharma Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Vashist Sandhu
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Vashist Sandhu
Vashist Sandhu currently holds 4 directorships: Vaxova Drugs Private Limited (Director, since 06 Mar 2021, revenue ₹26.09 Cr (FY 2024)); Alfavision Biotech Private Limited (Director, since 29 Oct 2020, revenue ₹10.68 Cr (FY 2025)); Deltis Pharma Private Limited (Director, since 05 Feb 2021, revenue ₹1.37 Cr (FY 2023)); Vaxova Life Sciences Private Limited (Director, since 08 Oct 2021).
Vashist Sandhu was first appointed on 29 Oct 2020 as Director at Alfavision Biotech Private Limited. The most recent appointment on record is 08 Oct 2021 at Vaxova Life Sciences Private Limited.
The 3 current companies of Vashist Sandhu that report revenue have a combined latest revenue of ₹38.14 Cr: Vaxova Drugs Private Limited ₹26.09 Cr (FY 2024); Alfavision Biotech Private Limited ₹10.68 Cr (FY 2025); Deltis Pharma Private Limited ₹1.37 Cr (FY 2023).
Vashist Sandhu held 3 earlier board appointments: Aconwell Pharma Private Limited (Director, 12 Nov 2020 to 31 Jul 2024); Anvicure Drugs Private Limited (Director, 17 Apr 2021 to 26 Mar 2024); Indmark Biotech Private Limited (Director, 13 Sep 2021 to 11 Aug 2023).
The current boards of Vashist Sandhu's companies include Ankush Kumar (Vaxova Drugs Private Limited), Narender (Vaxova Drugs Private Limited), Rocky (Alfavision Biotech Private Limited), Sachin Kumar (Alfavision Biotech Private Limited), Sher Singh (Deltis Pharma Private Limited).